Shandong Xinhua Pharmaceutical Announces RMB 0.15 Final Dividend for FY 2025

Bulletin Express03-27

Shandong Xinhua Pharmaceutical Company Limited has declared a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025, according to its announcement dated 27 March 2026. The distribution remains subject to shareholder approval, with the record date, ex-dividend date, payment date, and related Hong Kong share-register details yet to be disclosed.

The company has not provided the applicable exchange rate for shareholders receiving the dividend in Hong Kong dollars. Withholding-tax arrangements, if any, will be announced at a later stage.

Computershare Hong Kong Investor Services Limited will act as the share registrar for entitlement determination once the timetable is confirmed.

As of the announcement date, the board consists of Executive Chairman He Tongqing, executive directors Xu Wenhui and Hou Ning, non-executive directors Xu Lie and Zhang Chengyong, and independent non-executive directors Pan Guangcheng, Zhu Jianwei, Ling Peixue, and Cheung Ching Ching, Daisy.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1116236609?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116236609","market":"us","top_or_hot":-1,"title":"Shandong Xinhua Pharmaceutical Announces RMB 0.15 Final Dividend for FY 2025","media":"Bulletin Express","content":"<p>Shandong Xinhua Pharmaceutical Company Limited has declared a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025, according to its announcement dated 27 March 2026. The distribution remains subject to shareholder approval, with the record date, ex-dividend date, payment date, and related Hong Kong share-register details yet to be disclosed.</p>\n<p>The company has not provided the applicable exchange rate for shareholders receiving the dividend in Hong Kong dollars. Withholding-tax arrangements, if any, will be announced at a later stage.</p>\n<p>Computershare Hong Kong Investor Services Limited will act as the share registrar for entitlement determination once the timetable is confirmed.</p>\n<p>As of the announcement date, the board consists of Executive Chairman He Tongqing, executive directors Xu Wenhui and Hou Ning, non-executive directors Xu Lie and Zhang Chengyong, and independent non-executive directors Pan Guangcheng, Zhu Jianwei, Ling Peixue, and Cheung Ching Ching, Daisy.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shandong Xinhua Pharmaceutical Announces RMB 0.15 Final Dividend for FY 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShandong Xinhua Pharmaceutical Announces RMB 0.15 Final Dividend for FY 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-27 16:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Xinhua Pharmaceutical Company Limited has declared a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025, according to its announcement dated 27 March 2026. The distribution remains subject to shareholder approval, with the record date, ex-dividend date, payment date, and related Hong Kong share-register details yet to be disclosed.</p>\n<p>The company has not provided the applicable exchange rate for shareholders receiving the dividend in Hong Kong dollars. Withholding-tax arrangements, if any, will be announced at a later stage.</p>\n<p>Computershare Hong Kong Investor Services Limited will act as the share registrar for entitlement determination once the timetable is confirmed.</p>\n<p>As of the announcement date, the board consists of Executive Chairman He Tongqing, executive directors Xu Wenhui and Hou Ning, non-executive directors Xu Lie and Zhang Chengyong, and independent non-executive directors Pan Guangcheng, Zhu Jianwei, Ling Peixue, and Cheung Ching Ching, Daisy.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00719","symbol_name":"山东新华制药股份","start_time":0,"source_url":"","article_id":"1116236609","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116236609","pubTimestamp":1774601145,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Xinhua Pharmaceutical Company Limited has declared a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025, according to its announcement dated 27 March...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00719":"山东新华制药股份"},"translate_title":"山东新华制药宣派2025财年末期股息人民币0.15元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00719":1},"content_text":"Shandong Xinhua Pharmaceutical Company Limited has declared a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025, according to its announcement dated 27 March 2026. The distribution remains subject to shareholder approval, with the record date, ex-dividend date, payment date, and related Hong Kong share-register details yet to be disclosed.\nThe company has not provided the applicable exchange rate for shareholders receiving the dividend in Hong Kong dollars. Withholding-tax arrangements, if any, will be announced at a later stage.\nComputershare Hong Kong Investor Services Limited will act as the share registrar for entitlement determination once the timetable is confirmed.\nAs of the announcement date, the board consists of Executive Chairman He Tongqing, executive directors Xu Wenhui and Hou Ning, non-executive directors Xu Lie and Zhang Chengyong, and independent non-executive directors Pan Guangcheng, Zhu Jianwei, Ling Peixue, and Cheung Ching Ching, Daisy.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1116236609","isCrawlerRequest":true}